Allied Minds is a diversified holding company focused on venture creation within the life science and technology sectors. With unparalleled access to hundreds of university and federal labs across the U.S., Allied Minds forms, funds, and operates a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, with nationwide presence in Los Angeles and New York, Allied Minds supports its businesses with capital, central management, and shared services.
Our cross-disciplinary team hails from industry, academia, and government, and uniquely combines a deep understanding of the early-stage innovation ecosystem and technology transfer, proven scientific and technical expertise, and decades of operational experience in technology-driven, high-growth companies.
We are based in Boston, with nationwide presence in Los Angeles and New York. Our companies are located across the country, co-located with the talent and facilities they need to grow and thrive.
We are at the forefront of technology transfer and venture creation within the life science and technology sectors. We manage a diversified portfolio of over 20 subsidiary businesses at varying stages of commercial maturity across a wide range of life sciences and technology sectors, including medical devices, diagnostics, biopharmaceuticals, big data, cyber security, communications, semiconductors, and food safety.
To-date, we’ve raised more than $550M in capital, including $150M from our June 2014 IPO. Our portfolio companies also attract direct investments from institutional investors, corporate venture partners, family offices, and other leading venture capital groups.
We generally serve as the lead investor through which we take and maintain majority control, and almost all of our companies start out with a seed investment. On occasion, we may sponsor a proof of concept or killer experiment in the university (SRA) or federal lab (CRADA) prior to making an investment.
Size of Investments
Our seed investments range from $250,000 to $1 million, and our Series A investments from $5M to $10M. For larger Series A and follow-on rounds, we will continue to invest alongside a syndicate.
We currently manage a robust portfolio of over 20 game-changing companies.